AbbVie | ABBV - Lucro Operacional

Preço das Ações
205.07
Mudança Diária
-1.16 -0.56%
Mensal
-10.64%
Anual
-2.35%
Q1 Previsão
213.05




Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
Abbott USD 2.25B 73M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
J&J USD 5.59B 1.81B 2025-12
Medtronic USD 1.74B 40M 2025-12
Merck USD 6.24B 318M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 437M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
UCB EUR 1.29B 571M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Zoetis USD 835M 101M 2025-12